Legal & General Group PLC Kronos Bio, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $1,390 - $2,303	415 Added 13.4%	3,512 $12,000
Q2 2022 Aug 22, 2022	SELL	$3.12 - $7.52 $15,300 - $36,878	-4,904 Reduced 61.29%	3,097 $11,000
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $60,378 - $82,078	3,323 Added 71.03%	8,001 $167,000
Q2 2021 Aug 12, 2021	BUY	$20.08 - $29.02 $63,934 - $92,399	3,184 Added 213.12%	4,678 $112,000
Q1 2021 May 17, 2021	SELL	$27.0 - $32.48 $1,944 - $2,338	-72 Reduced 4.6%	1,494 $44,000
Q4 2020 Feb 12, 2021	BUY	$26.68 - $38.23 $41,780 - $59,868	1,566 New	1,566 $47,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.